Growth Update - Case Based Approach to short stature

Speciality: Pediatrics


Speaker:

Dr. Ankita Maheshwari - Moderator | Consultant Pediatric & Adolescent Endocrinologist. MD Pediatrics , PDF ( Pediatric Endocrinology)

Dr. Nikhil Lohiya - Speaker | DNB Peds, PDCF( Ped Endo) , FCPE( Ped Endo) Consultant pediatric Endocrinologist.

Dr. Nikhil Avnish Shah - Speaker | Consultant Pediatric Endocrinologist

Description:

A warm welcome to all the medical professionals in this interesting session on Growth Update - Case Based Approach to short stature
A case-based approach to managing short stature provides a comprehensive framework for understanding and addressing the condition in pediatric patients. Short stature, defined as a height significantly below the average for a child's age and sex, can be caused by a variety of genetic, hormonal, and environmental factors. This approach involves detailed case evaluations to identify the underlying causes and determine the most appropriate interventions.
The first step in a case-based approach is a thorough evaluation of the patient’s medical history, growth patterns, and physical examination findings. Key assessments include growth charts, familial height patterns, and screening for chronic illnesses or nutritional deficiencies. Hormonal evaluations and genetic testing may also be necessary to pinpoint specific causes, such as growth hormone deficiencies or genetic syndromes.
Tailored treatment plans ensure that each patient receives the most effective and targeted intervention based on their unique condition and needs.
Therefore, get an overall knowledge of growth update - case based approach to short stature
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

2.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

3.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

4.

AI tool automates liver tumor detection and monitoring

5.

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot